Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
11,181,416
-
Total 13F shares
-
27,300,271
-
Share change
-
+1,627,995
-
Total reported value
-
$342,431,318
-
Price per share
-
$12.54
-
Number of holders
-
45
-
Value change
-
+$20,438,169
-
Number of buys
-
34
-
Number of sells
-
6
Institutional Holders of Ikena Oncology, Inc. - Common Stock, $0.001 par value (IKNA) as of Q4 2021
As of 31 Dec 2021,
Ikena Oncology, Inc. - Common Stock, $0.001 par value (IKNA) was held by
45 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
27,300,271 shares.
The largest 10 holders included
Atlas Venture Life Science Advisors, LLC, FMR LLC, ORBIMED ADVISORS LLC, Omega Fund Management, LLC, CITADEL ADVISORS LLC, BVF INC/IL, Artal Group S.A., BlackRock Inc., FARALLON CAPITAL MANAGEMENT LLC, and CHI Advisors LLC.
This page lists
45
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.